Inovio Pharmaceuticals
INO
#8585
Rank
A$0.39 B
Marketcap
A$2.12
Share price
-2.05%
Change (1 day)
-30.20%
Change (1 year)

Market capitalization of Inovio Pharmaceuticals (INO)

Market cap: A$0.39 Billion

As of November 2026 Inovio Pharmaceuticals has a market cap of A$0.39 Billion. This makes Inovio Pharmaceuticals the world's 8585th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Inovio Pharmaceuticals from 1998 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.39 B68.69%
2025A$0.23 B116.43%
2024A$0.10 B-46.89%
2023A$0.20 B-64.27%
2022A$0.57 B-60.5%
2021A$1.44 B-25.73%
2020A$1.94 B308.13%
2019A$0.47 B-13.46%
2018A$0.55 B15.57%
2017A$0.47 B-33.01%
2016A$0.71 B7.04%
2015A$0.66 B-2.22%
2014A$0.68 B-0.35%
2013A$0.68 B885.71%
2012A$69.36 M30.57%
2011A$53.12 M-55.33%
2010A$0.11 B-8.8%
2009A$0.13 B301.96%
2008A$32.43 M-29.64%
2007A$46.1 M-69.01%
2006A$0.14 B62.7%
2005A$91.42 M-2.52%
2004A$93.78 M-12.43%
2003A$0.10 B327.56%
2002A$25.04 M-40.84%
2001A$42.33 M-24.91%
2000A$56.38 M-49%
1999A$0.11 B-5.66%
1998A$0.11 B

End of Day market cap according to different sources

On Nov 15th, 2026 the market cap of Inovio Pharmaceuticals was reported to be:

A$0.39 Billion
by Nasdaq info icon info icon
A$0.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$1.017 T 256,719.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$448.41 B 113,069.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$243.59 B 61,378.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$308.39 B 77,733.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$538.85 B 135,896.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$149.59 B 37,654.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
A$72.58 M-81.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$9.99 B 2,421.78%๐Ÿ‡บ๐Ÿ‡ธ USA